• 1
    de Laet CEDH, van Hout BA, Burger H, Hofman A, Pols HAP. Bone density and the risk of hip fracture in men and women: cross sectional analysis. BMJ. 1997; 315: 2215.
  • 2
    Kanis JA, Odén A, McCloskey EV, Johansson H, Wahl DA, Cooper C, IOF Working Group on Epidemiology and Quality of Life. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012 Mar 15. [Epub ahead of print].
  • 3
    Sànchez-Riera L, Wilson N, Kamalaraj N, Nolla JM, Kok C, Li Y, Macara M, Norman R, Chen JS, Smith EU, Sambrook PN, Hernández CS, Woolf A, March L. Osteoporosis and fragility fractures. Best Pract Res Clin Rheumatol. 2010; 24(6): 793810.
  • 4
    McCready BR, Goldstein SA. Biomechanics of fracture: is bone mineral density sufficient to assess risk? J Bone Miner Res. 2000; 15(12): 23058.
  • 5
    Gourion-Arsiquaud S, Burket JC, Havill LM, DiCarlo E, Doty SB, Mendelsohn R, van der Meulen MC, Boskey AL. Spatial variation in osteonal bone properties relative to tissue and animal age. J Bone Miner Res. 2009; 24(7): 127181.
  • 6
    Donnelly E. Methods for assessing bone quality: a review. Clin Orthop Relat Res. 2011; 469(8): 212838.
  • 7
    Black DM, Bouxsein ML, Marshall LM, Cummings SR, Lang TF, Cauley JA, Ensrud KE, Nielson CM, Orwoll ES. Osteoporotic Fractures in Men (MrOS) Research Group. Proximal femoral structure and the prediction of hip fracture in men: a large prospective study using QCT. J Bone Miner Res. 2008; 23(8): 132633.
  • 8
    Kaptoge S, Beck TJ, Reeve J, Stone KL, Hillier TA, Cauley JA, Cummings SR. Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the Study of Osteoporotic Fractures. J Bone Miner Res. 2008; 23(12): 189204.
  • 9
    Larrue A, Rattner A, Peter ZA, Olivier C, Laroche N, Vico L, Peyrin F. Synchrotron radiation micro-CT at the micrometer scale for the analysis of the three-dimensional morphology of microcracks in human trabecular bone. PLoS One. 2011; 6(7): e21297.
  • 10
    Bell KL, Loveridge N, Power J, Stanton M, Meggitt BF, Reeve J. Regional differences in cortical porosity in the fractured femoral neck. Bone. 1999; 24(1): 5764.
  • 11
    Bell GH, Dunbar O, Beck JS, Gibb A. Variations in strength of vertebrae with age and their relation to osteoporosis. Calcif Tissue Res. 1967; 1(1): 7586.
  • 12
    Gupta HS, Seto J, Wagermaier W, Zaslansky P, Boesecke P, Fratzl P. Cooperative deformation of mineral and collagen in bone at the nanoscale. Proc Natl Acad Sci USA. 2006; 103(47): 177416.
  • 13
    Viguet-Carrin S, Garnero P, Delmas PD. The role of collagen in bone strength. Osteoporos Int. 2006; 17(3): 31936.
  • 14
    Boskey AL, Mendelsohn R. Infrared spectroscopic characterization of mineralized tissues. Vib Spectrosc. 2005; 38(1–2): 10714.
  • 15
    Donnelly E, Meredith DS, Nguyen JT, Gladnick BP, Rebolledo BJ, Shaffer AD, Lorich DG, Lane JM, Boskey AL. Reduced cortical bone compositional heterogeneity with bisphosphonate treatment in postmenopausal women with intertrochanteric and subtrochanteric fractures. J Bone Miner Res. 2012; 27(3): 6728.
  • 16
    Gamsjaeger S, Buchinger B, Zwettler E, Recker R, Black D, Gasser JA, Eriksen EF, Klaushofer K, Paschalis EP. Bone material properties in actively bone-forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once-yearly Zoledronic acid. J Bone Miner Res. 2011; 26(1): 128.
  • 17
    Durchschlag E, Paschalis EP, Zoehrer R, Roschger P, Fratzl P, Recker RR, Phipps R, Klaushofer K. Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate. J Bone Miner Res. 2006; 21(10): 158190.
  • 18
    Fratzl P, Roschger P, Eschberger J, Abendroth B, Klaushofer K. Abnormal bone mineralization after fluoride treatment in osteoporosis: a small-angle X-ray-scattering study. J Bone Miner Res. 1994; 9(10): 15419.
  • 19
    Röschger P, Rinnerthaler S, Yates J, Rodan GA, Fratzl P, Klaushöfer K. Alendronate increases degree and uniformity of mineralisation in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. Bone. 2001; 29(2): 1851.
  • 20
    Gourion-Arsiquaud S, Allen MR, Burr DB, Vashishth D, Tang SY, Boskey AL. Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity. Bone. 2010; 46(3): 66672.
  • 21
    Ciarelli TE, Fyhrie DP, Parfitt AM. Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone. 2003; 32: 3115.
  • 22
    Keaveny TM, Hayes WC. A 20-year perspective on the mechanical properties of trabecular bone. J Biomech Eng. 1993; 115: 53442.
  • 23
    Renders GA, Mulder L, van Ruijven LJ, Langenbach GE, van Eijden TM. Mineral heterogeneity affects predictions of intratrabecular stress and strain. J Biomech. 2011; 44(3): 4027.
  • 24
    Erben RG. Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry. J Histochem Cytochem. 1997; 45(2): 30713.
  • 25
    Bell K, Loveridge N, Power J, Garrahan N, Stanton M, Lunt M, Meggitt B, Reeve J. Structure of the femoral neck in hip fracture: cortical bone loss in the inferoanterior to superoposterior axis. J Bone Miner Res. 1999; 14: 11220.
  • 26
    Bell K, Loveridge N, Power J, Rushton N, Reeve J. Intracapsular hip fracture: increased cortical remodelling in the thinned and porous anterior region of the femoral neck. Osteoporos Int. 1999; 10: 24857.
  • 27
    Gourion-Arsiquaud S, West PA, Boskey AL. Fourier transform-infrared microspectroscopy and microscopic imaging. Methods Mol Biol. 2008; 455: 293303.
  • 28
    Fritton JC, Myers ER, Wright TM, van der Meulen MC. Loading induces site-specific increases in mineral content assessed by microcomputed tomography of the mouse tibia. Bone. 2005; 36(6): 10308.
  • 29
    Sedgwick P. Multiple significance tests: the Bonferroni correction. BMJ. 2012; 344: e509.
  • 30
    Verdelis K, Ling Y, Sreenath T, Haruyama N, MacDougall M, van der Meulen MC, Lukashova L, Spevak L, Kulkarni AB, Boskey AL. DSPP effects on in vivo bone mineralization. Bone. 2008; 43(6): 98390.
  • 31
    Loveridge N, Power J, Reeve J, Boyde A. Bone mineralization density and femoral neck fragility. Bone. 2004; 35(4): 92941.
  • 32
    Fratzl-Zelman N, Roschger P, Gourrier A, Weber M, Misof BM, Loveridge N, Reeve J, Klaushofer K, Fratzl P. Combination of nanoindentation and quantitative backscattered electron imaging revealed altered bone material properties associated with femoral neck fragility. Calcif Tissue Int. 2009; 85(4): 33543.
  • 33
    Soicher MA, Wang X, Zauel RR, Fyhrie DP. Damage initiation sites in osteoporotic and normal human cancellous bone. Bone. 2011; 48(3): 6636.
  • 34
    Zimmermann EA, Schaible E, Bale H, Barth HD, Tang SY, Reichert P, Busse B, Alliston T, Ager JW III, Ritchie RO. Age-related changes in the plasticity and toughness of human cortical bone at multiple length scales. Proc Natl Acad Sci USA. 2011; 108(35): 1441621.
  • 35
    Busse B, Hahn M, Soltau M, Zustin J, Püschel K, Duda GN, Amling M. Increased calcium content and inhomogeneity of mineralization render bone toughness in osteoporosis: mineralization, morphology and biomechanics of human single trabeculae. Bone. 2009; 45: 103443.
  • 36
    Wand JS, Smith T, Green JR, Hesp R, Bradbeer JN, Reeve J. Whole body and site-specific bone remodelling in patients with previous femoral fractures. Relationships between reduced physical activity, reduced bone mass and increased bone resorption. Clin Sci. 1992; 83: 66575.
  • 37
    Power J, Doube M, van Bezooijen R, Loveridge N, Reeve J. Osteocyte recruitment declines as the osteon fills in: interacting effects of osteocytic sclerostin and previous hip fracture on the size of cortical canals in the femoral neck. Bone. 2012; 50(5): 110714.
  • 38
    Power J, Poole KE, van Bezooijen R, Doube M, Caballero-Alías AM, Lowik C, Papapoulos S, Reeve J, Loveridge N. Sclerostin and the regulation of bone formation: effects in hip osteoarthritis and femoral neck fracture. J Bone Miner Res. 2010; 25(8): 186776.
  • 39
    Ciarelli TE, Tjhia CK, Rao DS, Qiu S, Parfitt AM, Fyhrie DP. Trabecular packet-level lamellar density patterns differ by fracture status and bone formation rate in white females. Bone. 2009; 45: 9038.
  • 40
    Fratzl P, Gupta HS, Fischer FD, Kolednik O. Hindered crack propagation in materials with periodically varying Young's modulus—lessons from biological materials. Adv Materials. 2007; 19(18): 265761.
  • 41
    Bousson V, Bergot C, Wu Y, Jolivet E, Zhou LQ, Laredo JD. Greater tissue mineralization heterogeneity in femoral neck cortex from hip-fractured females than controls. A microradiographic study. Bone. 2011; 48: 12529.
  • 42
    Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Müller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010; 25(7): 146886.
  • 43
    Thomas CDL, Mayhew PM, Power J, Poole KES, Loveridge N, Clement JG, Burgoyne CJ, Reeve J. Femoral neck trabecular bone: loss with ageing and role in preventing fracture. J Bone Miner Res. 2009; 24: 180818.
  • 44
    Ruppel ME, Miller LM, Burr DB. The effect of the microscopic and nanoscale structure on bone fragility. Osteoporos Int. 2008; 19: 125165.
  • 45
    Lotz JC, Cheal EJ, Hayes WC. Stress distributions within the proximal femur during gait and falls: implications for osteoporotic fracture. Osteoporos Int. 1995; 5(4): 25261.
  • 46
    Rey C, Renugopalakrishnan V, Shimizu M, Collins B, Glimcher MJ. Fourier transform infrared spectroscopic study of the carbonate ions in bone mineral during aging. Calcif Tissue Int. 1991; 49(4): 2518.
  • 47
    Tarnowski CP, Ignelzi MA Jr, Wang W, Taboas JM, Goldstein SA, Morris MD. Earliest mineral and matrix changes in force-induced musculoskeletal disease as revealed by Raman microspectroscopic imaging. J Bone Miner Res. 2004; 19(1): 6471.
  • 48
    Kavukcuoglu NB, Patterson-Buckendahl P, Mann AB. Effect of osteocalcin deficiency on the nanomechanics and chemistry of mouse bones. J Mech Behav Biomed Mater. 2009; 2(4): 34854.
  • 49
    LeGeros RZ, Kijkowska R, Bautista C, LeGeros JP. Synergistic effects of magnesium and carbonate on properties of biological and synthetic apatites. Connect Tissue Res. 1995; 33(1–3): 2039.
  • 50
    Doi Y, Iwanaga H, Shibutani T, Moriwaki Y, Iwayama Y. Osteoclastic responses to various calcium phosphates in cell cultures. J Biomed Mater Res. 1999; 47(3): 42433.
  • 51
    Kent GN, Dodds RA, Klenerman L, Watts RW, Bitensky L, Chayen J. Changes in crystal size and orientation of acidic glycosaminoglycans at the fracture site in fractured necks of femur. J Bone Joint Surg Br. 1983; 65(2): 18994.
  • 52
    Augat P, Schorlemmer S. The role of cortical bone and its microstructure in bone strength. Age Ageing. 2006; 35(Suppl 2): ii2731.
  • 53
    Gao H, Ji B, Jager IL, Arzt E, Fratzl P. Materials become insensitive to flaws at nanoscale: lessons from nature. Proc Natl Acad Sci USA. 2003; 100(10): 5597600.
  • 54
    Boskey AL, DiCarlo E, Paschalis EP, West P, Mendelsohn R. Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation. Osteoporos Int. 2005; 16(12): 20318.
  • 55
    Gourion-Arsiquaud S, Faibish D, Myers E, Spevak L, Compston JE, Hodsman A, Shane E, Recker RR, Boskey ER, Boskey AL. Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture. J Bone Miner Res. 2009; 24(9): 156571.
  • 56
    Mashiba T, Hirano T, Turner CH, Forwood MR, Johnston CC, Burr DB. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res. 2000; 15(4): 61320.
  • 57
    Allen MR, Iwata K, Sato M, Burr DB. Raloxifene enhances vertebral mechanical properties independent of bone density. Bone. 2006; 39(5): 11305.
  • 58
    Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, Satterfield S, Wallace RB, Bauer DC, Palermo L, Wehren LE, Lombardi A, Santora AC, Cummings SR, FLEX Research Group. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. JAMA. 2006; 296(24): 292738.
  • 59
    Sebba A. Osteoporosis: how long should we treat? Curr Opin Endocrinol Diabetes Obes. 2008; 15(6): 5027.
  • 60
    Geusens P. Bisphosphonates for postmenopausal osteoporosis: determining duration of treatment. Curr Osteoporos Rep. 2009; 7(1): 127.
  • 61
    Tjhia CK, Odvina CV, Rao DS, Stover SM, Wang X, Fyhrie DP. Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients and normal subjects. Bone. 2011; 49: 127989.
  • 62
    O'Neill JM, Diab T, Allen MR, Vidakovic B, Burr DB, Guldberg RE. One year of alendronate treatment lowers microstructural stresses associated with trabecular microdamage initiation. Bone. 2010; 47(2): 2417.
  • 63
    Burket J, Gourion-Arsiquaud S, Havill LM, Baker SP, Boskey AL, van der Meulen MC. Microstructure and nanomechanical properties in osteons relate to tissue and animal age. J Biomech. 2011; 44(2): 27784.